Browsing by Yonsei Author : Kim, Jin Seok

eperson profile image
Name:
Kim, Jin Seok [김진석]
orcid http://orcid.org/0000-0001-8986-8436
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (55032033600)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 258

This table browses all dspace content
Issue DateTitleJournal Title
2023Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trialLANCET HAEMATOLOGY
2023Asia-Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific regionASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2023Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
2023Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea JOURNAL OF KOREAN MEDICAL SCIENCE
2023Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) FRONTIERS IN ONCOLOGY
2023Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2023Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study CANCER RESEARCH AND TREATMENT
2023Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trialEUROPEAN JOURNAL OF HAEMATOLOGY
2023A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneAMERICAN JOURNAL OF GASTROENTEROLOGY
2023Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from KoreaHAEMOPHILIA
2023Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 InhibitorsCLINICAL PHARMACOLOGY & THERAPEUTICS
2023Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study CANCER RESEARCH AND TREATMENT
2023Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA ANNALS OF HEMATOLOGY
2023Acute coronary syndrome in antineutrophil cytoplasmic antibody-associated vasculitis: a Korean single-centre cohort study Journal of Rheumatic Diseases
2023Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results HAEMATOLOGICA
2023Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH) BLOOD RESEARCH
2023The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report Korean Journal of Transplantation
2023Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts CANCER RESEARCH AND TREATMENT
2023DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation CANCERS
2022Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca StudyBLOOD
2022Interim Results of the Phase 1 Study of Tnb-486, a Novel CD19xCD3 T-Cell Engager, in Patients with Relapsed/Refractory (R/R) B-NHLBLOOD
2022Impact of BCL2/MYC Protein Dual Expression and Other Clinical Factors on the Risk of Central Nervous System Progression in Patients with Primary Breast Diffuse Large B-Cell LymphomaBLOOD
2022Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World StudyBLOOD
2022Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysisINTERNATIONAL JOURNAL OF HEMATOLOGY
2022Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary diseaseJOURNAL OF HEMATOLOGY & ONCOLOGY
2022Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR studyBRITISH JOURNAL OF HAEMATOLOGY
2022Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study BLOOD RESEARCH
2022국내 Human Research Protection Program 도입 과정과 발전 방향에 대한 고찰 Journal of KAIRB
2022Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study) FRONTIERS IN ONCOLOGY
2022Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2022Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myelomaBRITISH JOURNAL OF HAEMATOLOGY
2022Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)INTERNATIONAL JOURNAL OF HEMATOLOGY
2022Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma SCIENTIFIC REPORTS
2022An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment THERAPEUTIC ADVANCES IN HEMATOLOGY
2022Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study CANCER RESEARCH AND TREATMENT
2022Management of immune thrombocytopenia: 2022 update of Korean experts recommendations BLOOD RESEARCH
2022Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features CURRENT PROBLEMS IN CANCER
2022Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea CURRENT PROBLEMS IN CANCER
2022Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2022Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients JOURNAL OF MOLECULAR DIAGNOSTICS
2021Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea BLOOD RESEARCH
2021Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter studyANNALS OF HEMATOLOGY
2021Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study BLOOD ADVANCES
2021다발골수종 및 관련 형질세포 질환의 조기 진단을 위한 선별 검사 Korean Journal of Medicine
2021국내 임상시험 및 대상자 보호프로그램 도입 현황과 안전관리체계에 대한 설문조사 연구 Journal of Korean association of IRB
2021Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis KOREAN JOURNAL OF INTERNAL MEDICINE
2021Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trialANNALS OF HEMATOLOGY
2021Daratumumab-Based Treatment for Immunoglobulin Light-Chain AmyloidosisNEW ENGLAND JOURNAL OF MEDICINE
2021Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantationSUPPORTIVE CARE IN CANCER
2021Clinical characteristics and prognostic factors of acquired haemophilia A in KoreaHAEMOPHILIA

Browse

Links